Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 09 Mar 2023
Recent studies have shown poor outcomes in infants and children with postnatal development.
Read Full NewsNew York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.
The drug was previously approved for stage 2 T1D.
Findings suggest young females should be assessed and, if at risk, monitored.
Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.
Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.
The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.
Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.
1.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
2.
Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer
3.
PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.
4.
Durvalumab Wins FDA Approval in Limited-Stage SCLC
5.
Single-dose radiation before surgery can eradicate breast cancer
1.
Comprehensive Breakthroughs in Oncology for Better Care
2.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
3.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
4.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
5.
Cancer Cachexia: Emerging Therapeutic Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
4.
A New Era in Managing Cancer-Associated Thrombosis
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge